BCL2L1 and glioblastoma: Garcinol reduced glioblastoma tumor growth in an immunocompromised mouse model by reducing STAT3/STAT5A expression, enhancing the Bax/Bcl-XL apoptotic ratio, and downregulating the Ki-67 proliferation index, in vivo [86] (Table 1).